Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subspecialties Retina, Basic & Translational Research

Swimming Against the Nucleotides

Rewarding Work

Tomorrow’s cures for retinopathies will likely include advanced gene and cell therapies delivered by precision surgery

Translational research often requires both scientific and clinical input – and this demands collaboration between groups with complementary skill-sets. Developing gene or cell therapies for retinal disease requires sophisticated expertise in a range of disciplines from molecular biology to microsurgery. Close collaboration was critical for the 2017 approval of a gene therapy for Leber Congenital Amaurosis (LCA), which is a form of childhood blindness that can be caused by the lack of a gene called RPE65. The contribution of our team at UCL/Moorfields was recognized last year, when the 2018 Antonio Champalimaud Vision Award was awarded to the four groups working to develop gene therapy for this condition. Working on a new therapy for an unmet clinical need is its own reward – but it’s certainly an honor to receive such recognition!

Read the full article now

Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE!

Login

Or register now - it’s free!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

When you click “Register” we will email you a link, which you must click to verify the email address above and activate your account. If you do not receive this email, please contact us at [email protected].

About the Author

James Bainbridge

Professor of Retinal Studies, UCL Institute of Ophthalmology and Moorfields Eye Hospital London

Newsletter

Send me the latest from The Ophthalmologist.

Sign up now

Most Popular

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register